Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc Price Chart APLS

Historical daily share price chart and data for Apellis Pharmaceuticals Inc since 2017 adjusted for splits and dividends. The latest closing price for Apellis Pharmaceuticals Inc as of June 02, 2020 is $33.68.
  • In 2020 the stock opened at $30.96 and closed at $33.68 for a gain of 8% YTD.
  • In 2019 the stock opened at $12.91 and closed at $30.62 for a gain of 58%.
  • In 2018 the stock opened at $21.72 and closed at $13.19 for a loss of -65%.
  • In 2017 the stock opened at $14.50 and closed at $21.70 for a gain of 33%.
View Chart On Koyfin

Apellis Pharmaceuticals Inc Summary

Stock Symbol: APLS

Apellis Pharmaceuticals Inc Company Info

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is APL-2 that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria diseases; and in Phase II clinical trials for the treatment of cold agglutinin and warm antibody autoimmune hemolytic anemia diseases, as well as in Phase II clinical trials to treat four types of glomerular diseases, such as C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company is also developing APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for intravenous administration in systemic indications. It has a risk-sharing collaboration agreement with SFJ Pharmaceuticals Group for the development of APL-2 in hematologic indications. Apellis Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Crestwood, Kentucky.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
731.08 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of APLS Prices